{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:48:57Z","timestamp":1792054137093,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.psychres.2026.117288","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:18:56Z","timestamp":1781626736000},"page":"117288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Intranasal esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A multicenter real-world longitudinal study"],"prefix":"10.1016","volume":"364","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6684-7689","authenticated-orcid":false,"given":"Filippo","family":"Mazzoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1818-4237","authenticated-orcid":false,"given":"Fabiola","family":"Raffone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2991-3032","authenticated-orcid":false,"given":"Arianna","family":"De Ciechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaja","family":"Girone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-5897","authenticated-orcid":false,"given":"Monica","family":"Macellaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martinotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Dell\u2019Osso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3344-1000","authenticated-orcid":false,"given":"Vassilis","family":"Martiadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-0539","authenticated-orcid":false,"given":"Miriam","family":"Olivola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2026.117288_bib0001","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-med-053013-062946","article-title":"Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics","volume":"66","author":"Abdallah","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.psychres.2026.117288_bib0002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jad.2020.09.071","article-title":"Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis","volume":"278","author":"Bahji","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2026.117288_bib0003","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000173701","article-title":"The short version of the borderline symptom list (BSL-23): development and initial data on psychometric properties","volume":"42","author":"Bohus","year":"2009","journal-title":"Psychopathology,"},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0004","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0165-0327(98)00130-X","article-title":"Impulsivity: a relevant dimension in depression regarding suicide attempts?","volume":"53","author":"Corruble","year":"1999","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1037\/a0015616","article-title":"A biosocial developmental model of borderline personality: elaborating and extending Linehan\u2019s theory","volume":"135","author":"Crowell","year":"2009","journal-title":"Psychol. Bull."},{"issue":"11","key":"10.1016\/j.psychres.2026.117288_bib0006","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jagp.2023.06.016","article-title":"Investigating the effectiveness and tolerability of intranasal esketamine among older adults with treatment-resistant depression (TRD): a post-hoc analysis from the REAL-ESK study group","volume":"31","author":"d'Andrea","year":"2023","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2026.117288_bib0007","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1001\/jamapsychiatry.2019.1189","article-title":"Efficacy of esketamine nasal spray plus oral antidepressant treatment for relapse prevention in patients with treatment-resistant depression: a randomized clinical trial","volume":"76","author":"Daly","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117288_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamapsychiatry.2017.3739","article-title":"Efficacy and safety of intranasal esketamine adjunctive to oral antidepressant therapy in treatment-resistant depression: a randomized clinical trial","volume":"75","author":"Daly","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"10.1016\/j.psychres.2026.117288_bib0009","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1002\/da.23193","article-title":"The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder","volume":"38","author":"Daly","year":"2021","journal-title":"Depress. Anxiety."},{"issue":"2","key":"10.1016\/j.psychres.2026.117288_bib0010","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3390\/ph18020173","article-title":"Long-term cognitive outcomes of esketamine nasal spray in treatment-resistant depression: a preliminary report","volume":"18","author":"de Freitas Menezes Sobreiro","year":"2025","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.psychres.2026.117288_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1394787","article-title":"Facts and myths about use of esketamine for treatment-resistant depression: a narrative clinical review","volume":"15","author":"Di Vincenzo","year":"2024","journal-title":"Front. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0012","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.psychres.2026.117288_bib0013","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpsychires.2024.04.008","article-title":"Efficacy of esketamine among patients with treatment-resistant depression in a 'real world' health-care setting in Israel","volume":"174","author":"Dvorak","year":"2024","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0014","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1176\/appi.ajp.2007.06111868","article-title":"Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STARD report","volume":"165","author":"Fava","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2026.117288_bib0015","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ijnp\/pyz039","article-title":"Efficacy and safety of fixed-dose esketamine nasal spray combined with a new oral antidepressant in treatment-resistant depression: results of a randomized, double-blind, active-controlled study (TRANSFORM-1)","volume":"22","author":"Fedgchin","year":"2019","journal-title":"Int, J. Neuropsychopharmacol.,"},{"key":"10.1016\/j.psychres.2026.117288_bib0016","series-title":"Structured Clinical Interview for DSM-5 Personality Disorders (SCID-5-PD)","author":"First","year":"2016"},{"issue":"2","key":"10.1016\/j.psychres.2026.117288_bib0017","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/da.22968","article-title":"Defining treatment-resistant depression","volume":"37","author":"Gaynes","year":"2020","journal-title":"Depress. Anxiety."},{"issue":"8","key":"10.1016\/j.psychres.2026.117288_bib0018","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.4088\/JCP.v65n0804","article-title":"Major depressive disorder and borderline personality disorder revisited: longitudinal interactions","volume":"65","author":"Gunderson","year":"2004","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2026.117288_bib0019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/13811118.2011.565265","article-title":"Aggression, impulsivity, and suicide behavior: a review of the literature","volume":"15","author":"Gvion","year":"2011","journal-title":"Arch. Suicide Res."},{"issue":"1","key":"10.1016\/j.psychres.2026.117288_bib0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br. J. Med. Psychol."},{"key":"10.1016\/j.psychres.2026.117288_bib0021","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40479-020-00126-6","article-title":"A proposed severity classification of borderline symptoms using the borderline symptom list (BSL-23)","volume":"7","author":"Kleindienst","year":"2020","journal-title":"Borderline Personal. Disord. Emot. Dysregul."},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jad.2005.05.017","article-title":"Efficacy of pharmacotherapy in depressed patients with and without personality disorders: a systematic review and meta-analysis","volume":"88","author":"Kool","year":"2005","journal-title":"J. Affect. Disord."},{"issue":"9759","key":"10.1016\/j.psychres.2026.117288_bib0023","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0140-6736(10)61422-5","article-title":"Borderline personality disorder","volume":"377","author":"Leichsenring","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2026.117288_bib0024","first-page":"1","article-title":"Gender differences in suicidal and self-harming responses to esketamine: a real-world retrospective study","volume":"23","author":"Martiadis","year":"2025","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0025","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/wps.21120","article-title":"Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions","volume":"22","author":"McIntyre","year":"2023","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/cpp.3022","article-title":"Unified protocol versus self-acceptance group therapy for emotional disorders in people with severe shame","volume":"31","author":"Mohajerin","year":"2024","journal-title":"Clin. Psychol. PsychOther"},{"key":"10.1016\/j.psychres.2026.117288_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2025.120231","article-title":"Mentalization and emotional-cognitive rigidity as predictors of esketamine's effects on treatment-resistant depression: findings from a prospective observational study","volume":"392","author":"Olivola","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psychres.2026.117288_bib0028","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.psychres.2026.117288_bib0029","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"issue":"4","key":"10.1016\/j.psychres.2026.117288_bib0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1521\/pedi_2013_27_070","article-title":"Influence of personality on the outcome of treatment in depression: systematic review and meta-analysis","volume":"28","author":"Newton-Howes","year":"2014","journal-title":"J. Pers. Disord."},{"issue":"4","key":"10.1016\/j.psychres.2026.117288_bib0031","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12889","article-title":"Efficacy of esketamine augmentation in major depressive disorder: a meta-analysis","volume":"81","author":"Papakostas","year":"2020","journal-title":"J. Clin. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2026.117288_bib0032","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1","article-title":"Factor structure of the barratt impulsiveness scale","volume":"51","author":"Patton","year":"1995","journal-title":"J. Clin. Psychol."},{"issue":"4","key":"10.1016\/j.psychres.2026.117288_bib0033","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/PRA.0000000000000723","article-title":"Reduction in cognitive symptoms following intranasal esketamine administration in patients with chronic treatment-resistant depression: a 12-week case series","volume":"29","author":"Pepe","year":"2023","journal-title":"J. Psychiatr. Pract."},{"issue":"5","key":"10.1016\/j.psychres.2026.117288_bib0034","doi-asserted-by":"crossref","first-page":"612","DOI":"10.2174\/011570159X337670241029062524","article-title":"Esketamine treatment trajectory of patients with treatment-resistant depression in the mid and long-term run: data from REAL-ESK study group","volume":"23","author":"Rosso","year":"2024","journal-title":"Curr. Neuropharmacol."},{"issue":"6","key":"10.1016\/j.psychres.2026.117288_bib0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/appi.ajp.2019.19020172","article-title":"Efficacy and safety of flexibly dosed esketamine nasal spray combined with a newly initiated oral antidepressant in treatment-resistant depression: a randomized double-blind active-controlled study","volume":"176","author":"Popova","year":"2019","journal-title":"Am. J. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2026.117288_bib0036","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1017\/S0033291713002535","article-title":"Cognitive impairment in depression: a systematic review and meta-analysis","volume":"44","author":"Rock","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2026.117288_bib0037","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/7262794","article-title":"Use of esketamine nasal spray in patients with treatment-resistant depression in routine practice: a real-world French study","volume":"2024","author":"Samalin","year":"2024","journal-title":"Depress. Anxiety."},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0038","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/13651501.2022.2030757","article-title":"Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme","volume":"26","author":"Samalin","year":"2022","journal-title":"Int. J. Psychiatry Clin. Pract."},{"issue":"3","key":"10.1016\/j.psychres.2026.117288_bib0039","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1176\/appi.ajp.2010.10050695","article-title":"Relationship of personality disorders to the course of major depressive disorder in a nationally representative sample","volume":"168","author":"Skodol","year":"2011","journal-title":"Am. J. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126003483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178126003483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:24:20Z","timestamp":1792052660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178126003483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":39,"alternative-id":["S0165178126003483"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117288","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A multicenter real-world longitudinal study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2026.117288","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117288"}}